Clinical trial
Anti-Angiogenesis Treatment After Preoperative Chemotherapy: A Pilot Study in Women With Operable Breast Cancer
NCT00121134 is registered in ClinicalTrials.gov with Harold J. Burstein, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-Angiogenesis Treatment After Preoperative Chemotherapy: A Pilot Study in Women With Operable Breast Cancer
- Lead sponsor
- Harold J. Burstein, MD, PhD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- May 31, 2011
- Enrollment
- 164 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer